EMEA-001205-PIP02-19

Table of contents

Key facts

Active substance
Tecovirimat (monohydrate)
Therapeutic area
Infectious diseases
Decision number
P/0274/2020
PIP number
EMEA-001205-PIP02-19
Pharmaceutical form(s)
  • Powder for oral suspension
  • Capsule, hard
Condition(s) / indication(s)
Treatment of orthopoxvirus disease (smallpox, monkeypox, cowpox, and vaccinia)
Route(s) of administration
  • Oral use
  • Gastric use
Contact for public enquiries
SIGA Technologies, Inc.

E-mail: PLong@siga.com
Tel. +1 5417584823

 

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating